Letters A sunshine act for Europe

The dark side of the sun

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7024 (Published 01 November 2011) Cite this as: BMJ 2011;343:d7024
  1. Mark Wilson, director of medical ethics1,
  2. Miran Epstein, senior lecturer in medical ethics and law2
  1. 1Health Research Associates, Ottawa, ON, Canada K2B 6J4
  2. 2Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
  1. healthresearch{at}rogers.com

The US Sunshine Act raises a cautionary note.1 Its stress on transparency as a solitary measure to tackle commercial conflicts of interest will preserve the status quo.

The act assumes that disclosure of conflicts between commercial and consumer interests entails victory of the latter over the former—this is not true. It assumes that because such disclosure is …

View Full Text

Sign in

Log in through your institution

Subscribe